Lupe G. Salazar, MD
Dr. Salazar is a medical oncologist specializing in the treatment of breast cancer and prevention.Title
- Acting Instructor of Medicine, Division of Oncology, University of Washington School of Medicine
Clinical Expertise
Immunotherapy, endogenous tumor immunity, breast cancer treatment and prevention
Education And Training
- MD: University of Minnesota
- Residency: Internal Medicine, University of Minnesota
- Fellowship: Hematology/Oncology, University of Washington
Clinical Trials
Dr. Salazar is the SCCA lead investigator for the following clinical trials:
- Phase II Topical Imiquimod/wkly Abraxane (6578)
- HER2 Vaccination and Adoptive T Cell Therapy (UW-6658)
- Ampligen w/Vaccine Therapy for Stage II-IV HER2-Positive Breast Cancer (7425)

